Amoy Diagnostics Co Ltd (300685) — Working Capital to Net Assets Ratio
Amoy Diagnostics Co Ltd (300685) has a Working Capital to Net Assets ratio of 91.9% as of September 2025. Working capital of CN¥1.81 Billion (current assets of CN¥2.00 Billion minus current liabilities of CN¥182.73 Million) is measured against net assets of CN¥1.97 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Amoy Diagnostics Co Ltd (300685) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Amoy Diagnostics Co Ltd Working Capital to Net Assets (2012–2024)
This chart shows how Amoy Diagnostics Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 91.9%, reflecting working capital of CN¥1.81 Billion against net assets of CN¥1.97 Billion CNY. Check tangible net worth ratio of Amoy Diagnostics Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Amoy Diagnostics Co Ltd (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Amoy Diagnostics Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Amoy Diagnostics Co Ltd stock valuation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 86.5% | CN¥1.59 Billion | CN¥1.84 Billion | CN¥1.79 Billion | CN¥194.82 Million | ▲ +1.6 pp |
| 2023 | 84.9% | CN¥1.45 Billion | CN¥1.70 Billion | CN¥1.62 Billion | CN¥174.48 Million | ▲ +5.3 pp |
| 2022 | 79.6% | CN¥1.19 Billion | CN¥1.50 Billion | CN¥1.29 Billion | CN¥91.97 Million | ▲ +2.1 pp |
| 2021 | 77.5% | CN¥1.06 Billion | CN¥1.37 Billion | CN¥1.20 Billion | CN¥135.21 Million | ▲ +1.3 pp |
| 2020 | 76.1% | CN¥859.03 Million | CN¥1.13 Billion | CN¥1.01 Billion | CN¥149.73 Million | ▲ +3.3 pp |
| 2019 | 72.8% | CN¥656.84 Million | CN¥902.11 Million | CN¥797.41 Million | CN¥140.57 Million | ▲ +5.6 pp |
| 2018 | 67.2% | CN¥508.33 Million | CN¥756.74 Million | CN¥564.95 Million | CN¥56.62 Million | ▼ -5.3 pp |
| 2017 | 72.4% | CN¥470.26 Million | CN¥649.20 Million | CN¥509.36 Million | CN¥39.10 Million | ▲ +17.5 pp |
| 2016 | 54.9% | CN¥169.05 Million | CN¥307.91 Million | CN¥205.82 Million | CN¥36.77 Million | ▲ +6.7 pp |
| 2015 | 48.2% | CN¥119.53 Million | CN¥247.90 Million | CN¥165.24 Million | CN¥45.71 Million | ▲ +41.9 pp |
| 2014 | 6.3% | CN¥5.54 Million | CN¥87.54 Million | CN¥67.74 Million | CN¥62.20 Million | ▲ +14.2 pp |
| 2013 | -7.9% | CN¥-3.10 Million | CN¥39.30 Million | CN¥48.31 Million | CN¥51.41 Million | ▲ +17.5 pp |
| 2012 | -25.4% | CN¥-4.38 Million | CN¥17.25 Million | CN¥33.20 Million | CN¥37.58 Million | — |